Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR
Research
Large-scale gene editing tool could power novel genetic meds
The method could lead to therapies that can address multiple different disease-causing genetic mutations.
Darren Incorvaia
Mar 11, 2026 12:00pm
FDA fully releases clinical hold on Intellia CRISPR trials
Mar 2, 2026 10:55am
FDA illuminates new approval pathway for bespoke gene therapies
Feb 23, 2026 11:30am
FDA frees Intellia of 1 clinical hold for CRISPR therapy
Jan 27, 2026 10:54am
Inside Beam's 'big push' for in vivo gene editing
Jan 21, 2026 7:52am
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am